Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox to Present at 2017 Bloom Burton & Co. Healthcare Investor Conference
25 avr. 2017 16h45 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, April 25, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox to Present at the 16th Annual Needham Healthcare Conference
29 mars 2017 16h30 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, March 29, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox Announces Appointment of Dr. Kelvin Neu and Dr. Richard Levy to Board of Directors
27 mars 2017 16h05 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, March 27, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox to Present at the Oppenheimer & Co. 27th Annual Healthcare Conference
14 mars 2017 16h30 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, March 14, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox Pharmaceuticals Announces Year End 2016 Financial Results
09 mars 2017 16h06 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, March 09, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox Pharmaceuticals to Announce 2016 Year End Financial Results
02 mars 2017 16h35 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, March 02, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox to Present at Leerink Partners 6th Annual Global Healthcare Conference
09 févr. 2017 09h15 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Feb. 09, 2017 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox and the University of Southampton Announce Presentation of Abstract at American Society of Hematology Annual Meeting
22 nov. 2016 09h15 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Nov. 22, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox Pharmaceuticals Announces Third Quarter 2016 Financial Results
09 nov. 2016 09h05 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Nov. 09, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...
Neoleukin_Logo_Stacked_FullColor_Square_RGB.jpg
Aquinox Announces Appointment of Dr. Barbara Troupin as Chief Medical Officer
03 oct. 2016 09h15 HE | Aquinox Pharmaceuticals, Inc.
VANCOUVER, British Columbia, Oct. 03, 2016 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“Aquinox”) (NASDAQ:AQXP), a clinical-stage pharmaceutical company discovering and developing targeted...